Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zolbetuximab by Astellas Pharma for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Pre-Registration for Adenocarcinoma Of The Gastroesophageal Junction. According to...
Zolbetuximab by Astellas Pharma for Gastric Cancer: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Pre-Registration for Gastric Cancer. According to GlobalData, Pre-Registration drugs...
Zolbetuximab by Astellas Pharma for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According...